Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Complement-driven NETosis mediates immunotherapy resistance in STK11-mutant lung adenocarcinoma.

PURPOSE Lung adenocarcinomas (LUADs) harboring concurrent mutations in KRAS and STK11 define a clinically aggressive subgroup characterized by primary resistance to immune checkpoint inhibitors (ICIs). In contrast, KRAS/TP53 co-mutant tumors typically exhibit an inflamed tumor microenvironment (TME) and improved respon...

Carlos E. de Andrea, D. Ajona, C. Sainz et al. · 0 citations
Open access Oct 2026

Development and Validation of an Automated Image-Based Method for Prognostic Stratification in Lung Adenocarcinoma using Immunohistochemical Markers

We present an automated image-based framework for quantifying biomarker expression in immunohistochemical (IHC) images and introduce the Marker Expression Level (MEL) score as an objective alternative to visual H-scoring. MEL addresses key limitations of existing automated methods by integrating tissue-region segmentat...

F. Carraro, M. Sangüesa, A. Irisarri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.